Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
28 /100
MEDIUM RISK
Score updated Aug 28, 2026

AGL — agilon health, inc. Dilution Risk Tracker

Track AGL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AGL — Get alerts when the score changes →

As of August 28, 2026, agilon health, inc. (AGL) has a DilutionWatch DilutionScore of 28/100, rated MEDIUM dilution risk. agilon health, inc. has a market capitalization of $1.54B, 16.79M shares outstanding, 13 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
37
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for AGL.
🔔 Track AGL — Get forecast alerts →

Market Data

Market Cap$1.54B
Shares Outstanding16.79M
Float9.83M
Cash$529.68M
Debt$30.29M
Short InterestN/A

Institutional Holdings

QoQ: ↓ 56.2% shares (2026Q1 vs prior)
13 institutional holders · 165.77M shares
#1 MORGAN STANLEY 113.26M shares
#2 Rubicon Founders LLC 25.32M shares
#3 GOLDMAN SACHS GROUP INC 20.06M shares
+ 10 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest872.2K
Days to Cover2.7
% of Float8.9%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2021-12-31
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-16
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-04-03
Full SEC filing analysis available with free account

Recent News

No recent news

Factual AGL Dilution Snapshot

agilon health, inc. (AGL) has a DilutionScore of 28/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track AGL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AGL — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for AGL
AGL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.